# Alimera Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alimera-sciences

- Industry: Pharmaceuticals
- Headquarters: Alpharetta, US
- Website: www.alimerasciences.com
- Total disclosed funding: $109M
- Latest round: Series C (Aug 25, 2009)
- Investors on record: 5

## About

Established in 2003 by Dan Myers and Dave Holland, and based in Georgia, US, Alimera Sciences, Inc. operates as a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The firm trades on NASDAQ under the ticker symbol ALIM. In April 2021, Alimera Sciences, Inc. raised USD 20 million in PIPE funding from investor OcuMension, a portfolio company of 6 Dimensions Capital, Boyu Capital, and Temasek Holdings.

Alimera Sciences is a global pharmaceutical company focused on retinal health. They develop innovative treatments for retinal diseases, aiming to improve vision and quality of life for patients. Their products address conditions affecting the retina and offer retinal disease therapies to better serve aging populations.

## Funding rounds

- Series C, Aug 25, 2009, $5M — Domain Associates, Intersouth Partners, Polaris Partners, Venrock, Scale Venture Partners
- Series C, Mar 18, 2008, $30M — Domain Associates, Intersouth Partners, Polaris Partners, Venrock, Scale Venture Partners
- Series B, Nov 27, 2006, $15M — Domain Associates, Intersouth Partners, Polaris Partners, Venrock, Scale Venture Partners
- Series B, Nov 30, 2005, $32M — Domain Associates, Intersouth Partners, Polaris Partners, Venrock, Scale Venture Partners
- Series A, Jul 1, 2004, $27M — Domain Associates, Intersouth Partners, Polaris Partners, Scale Venture Partners

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A, Series B, Series C
- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series A, Series B, Series C
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B, Series C
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series A, Series B, Series C
- Venrock (https://capitalatlas.ai/funds/venrock) — Series B, Series C